What we offer, and how we decide

Elective. Not FDA-approved. Explained in full.

Nuvira offers two therapies, cellular & biologic therapies and peptide programs, inside one coordinated plan with a scheduled day-90 review and one point of contact. We lead with the status because you'd want to know it before anything else.

Candidacy is decided at consultation. Individual results vary. No outcome is promised.

Two therapiesCellular & biologic therapies, and peptide programs
One written planOptions, risks, evidence and cost, before anything is scheduled
One point of contactFrom the first conversation through the day-90 review
A day-90 reviewScheduled, and included in every program

Read this first

Three things to know before the details

A page like this could tuck this part into the small print. We think it is the most useful thing we can tell you, so it goes first.

01

It's elective

Elective means chosen. Nothing on this page is something you must have, so you can take your time, ask hard questions, and say no.

02

It's not FDA-approved

These therapies have not been approved by the U.S. Food and Drug Administration. We won't promise an outcome, on this page or in person. Individual results vary.

03

It's decided at consultation

Candidacy is decided at consultation, by the treating clinician. Not by this page, not by a quiz, and not by enthusiasm, yours or ours. The answer can be no.

What “not FDA-approved” means, in plain words

What we offer

Two therapies, one plan

Nuvira is built around a single coordinated plan. Which therapy belongs in yours, if any, is for the treating clinician to say after a review. It is not a package chosen from a shelf.

Cellular & biologic therapies

Umbilical cord–derived biologic preparations, selected and administered under clinical supervision. Sourcing, handling, and what is known and not yet known are reviewed with you first.

What is reviewed, and what the day involves

Elective. Not FDA-approved. Candidacy is decided at consultation.

Peptide programs

Structured programs of 12–16 weeks, reviewed by the treating clinician. A peptide is prescribed only when the clinician judges it appropriate for you, and filled through a licensed compounding pharmacy.

What a program is, and what it isn't

Elective. Compounded medications are not FDA-approved. Candidacy is decided at consultation.

Day-90 follow-up
A scheduled review around day 90, included in every program. What comes next, if anything, is decided then and never assumed ahead of time.
Concierge coordination
One point of contact throughout. We come to you, at a date and a place agreed in advance. Which setting is appropriate is your clinician's call. Group visits can be arranged. How visits work
Pricing
Individualized. Discussed at consultation and given to you in writing before anything is scheduled.
The order of things
Five steps, from a no-pressure conversation to the day-90 review. See how it works

Utah law requires us to give you this notice

THIS NOTICE MUST BE PROVIDED TO YOU UNDER UTAH LAW. This health care practitioner performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing a stem cell therapy.

Utah Code 58-1-512 · What this notice means

Who is a candidate

The answer can be no

Candidacy is a clinical decision, made at consultation by the treating clinician. It is not a formality on the way to a booking.

  1. 1

    You talk to a person

    A no-pressure conversation about what brings you here. Please keep health details out of the website. A name and a way to reach you is enough to begin.

  2. 2

    The clinician reviews

    The treating clinician reviews whether any therapy is appropriate for you. No form, quiz or sales call decides this for you. Our own fit check only tells you whether a conversation makes sense.

  3. 3

    You hear the answer plainly

    If a therapy is appropriate for you, the clinician says which. If none is, you hear that just as clearly. If we're not the right fit, we'll say so.

  4. 4

    The decision stays yours

    A yes from us is not a yes from you. Keep the written plan. Show it to your own doctor. Decide in your own time.

Take the 2-minute fit check

Whatever is proposed

What every option comes with

The therapy differs from one person to the next. What surrounds it does not.

How to read a treatment plan

  • A written plan. Plain language, in one place, yours to keep. It covers your options, the risks, the evidence and the cost.
  • The risks, said out loud. Every option comes with a candid account of what could go wrong. You hear it before you decide, not after.
  • What isn't known. Where the evidence runs out, we say where. “Not yet known” is an answer you will hear from us.
  • The cost, in writing. Pricing is individualized. You have the figure in writing before anything is scheduled.
  • Room for your own doctor. Nuvira is a complement to your own physician, never a replacement. The plan is written to be shared with them.
  • A review already scheduled. A scheduled review around day 90, included in every program. What comes next, if anything, is decided then.

The detail

Read the page that applies to you

Each one covers what is reviewed with you, how it runs, and where the limits are.

Both are elective and not FDA-approved. Candidacy is decided at consultation. Individual results vary, and no outcome is promised.

Questions to ask any regenerative clinic, including this one

The first step

Start with a conversation.

One conversation. No pressure, no pitch. If we're not the right fit, we'll say so.

Elective wellness services. Not FDA-approved to treat any condition. Individual results vary.